| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Occupational Diseases | 6 | 2021 | 130 | 1.230 |
Why?
|
| Protein Kinase C-epsilon | 6 | 2020 | 33 | 1.010 |
Why?
|
| Laboratory Animal Science | 2 | 2019 | 24 | 0.950 |
Why?
|
| Occupational Exposure | 4 | 2021 | 244 | 0.940 |
Why?
|
| Animals, Laboratory | 3 | 2019 | 44 | 0.900 |
Why?
|
| Occupational Health | 1 | 2021 | 95 | 0.760 |
Why?
|
| Mice, Hairless | 2 | 2012 | 55 | 0.760 |
Why?
|
| Animals, Genetically Modified | 2 | 2019 | 406 | 0.700 |
Why?
|
| Genetic Background | 1 | 2019 | 8 | 0.690 |
Why?
|
| Health Status Disparities | 1 | 2021 | 291 | 0.630 |
Why?
|
| Mice | 48 | 2024 | 34495 | 0.620 |
Why?
|
| Cathepsin L | 3 | 2011 | 25 | 0.530 |
Why?
|
| Rats | 6 | 2024 | 6086 | 0.530 |
Why?
|
| Cathepsins | 2 | 2006 | 46 | 0.490 |
Why?
|
| Mice, Inbred SENCAR | 4 | 2006 | 13 | 0.480 |
Why?
|
| Skin Neoplasms | 11 | 2015 | 4654 | 0.470 |
Why?
|
| Mammary Neoplasms, Experimental | 4 | 2024 | 494 | 0.440 |
Why?
|
| Mice, Inbred Strains | 3 | 2006 | 521 | 0.430 |
Why?
|
| Animals | 54 | 2024 | 59536 | 0.420 |
Why?
|
| Prostatic Intraepithelial Neoplasia | 2 | 2011 | 84 | 0.400 |
Why?
|
| Microsatellite Repeats | 5 | 2009 | 575 | 0.400 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2019 | 2291 | 0.350 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2012 | 388 | 0.340 |
Why?
|
| Models, Animal | 1 | 2012 | 664 | 0.340 |
Why?
|
| Mice, Mutant Strains | 7 | 2017 | 634 | 0.330 |
Why?
|
| Disease Models, Animal | 6 | 2020 | 7222 | 0.320 |
Why?
|
| Cysteine Endopeptidases | 2 | 2006 | 251 | 0.300 |
Why?
|
| Mice, Transgenic | 14 | 2024 | 4143 | 0.300 |
Why?
|
| Alopecia | 3 | 2021 | 126 | 0.290 |
Why?
|
| Prostatic Neoplasms | 6 | 2018 | 5767 | 0.290 |
Why?
|
| Acyltransferases | 2 | 2017 | 62 | 0.290 |
Why?
|
| Colorectal Neoplasms, Hereditary Nonpolyposis | 2 | 2022 | 469 | 0.270 |
Why?
|
| Mice, Inbred BALB C | 7 | 2011 | 2314 | 0.270 |
Why?
|
| Polymerase Chain Reaction | 5 | 2009 | 3203 | 0.270 |
Why?
|
| Lymphoma | 2 | 2022 | 1467 | 0.270 |
Why?
|
| Skin Diseases | 1 | 2008 | 349 | 0.260 |
Why?
|
| Musculoskeletal Pain | 2 | 2017 | 21 | 0.260 |
Why?
|
| Helicobacter | 1 | 2004 | 14 | 0.260 |
Why?
|
| Mice, Knockout | 8 | 2020 | 5710 | 0.250 |
Why?
|
| Loss of Heterozygosity | 3 | 2009 | 602 | 0.250 |
Why?
|
| Membrane Proteins | 4 | 2020 | 2819 | 0.240 |
Why?
|
| Central America | 2 | 2021 | 29 | 0.240 |
Why?
|
| Aneuploidy | 1 | 2005 | 369 | 0.240 |
Why?
|
| Precancerous Conditions | 1 | 2011 | 1058 | 0.240 |
Why?
|
| Neoplasms, Hormone-Dependent | 1 | 2005 | 342 | 0.240 |
Why?
|
| Coal Tar | 1 | 2003 | 1 | 0.230 |
Why?
|
| Alleles | 5 | 2013 | 2437 | 0.220 |
Why?
|
| Point Mutation | 1 | 2005 | 769 | 0.220 |
Why?
|
| DNA, Bacterial | 1 | 2004 | 558 | 0.210 |
Why?
|
| Hair Follicle | 1 | 2002 | 64 | 0.210 |
Why?
|
| Keratinocytes | 3 | 2015 | 241 | 0.210 |
Why?
|
| Mutation | 8 | 2021 | 15179 | 0.210 |
Why?
|
| MutL Protein Homolog 1 | 2 | 2022 | 206 | 0.210 |
Why?
|
| Genes, p53 | 2 | 2005 | 1090 | 0.200 |
Why?
|
| Ageism | 1 | 2021 | 4 | 0.200 |
Why?
|
| Ectodermal Dysplasia | 1 | 2021 | 39 | 0.200 |
Why?
|
| Nail Diseases | 1 | 2021 | 40 | 0.200 |
Why?
|
| Occupations | 1 | 2021 | 50 | 0.200 |
Why?
|
| Polymorphism, Genetic | 2 | 2011 | 1450 | 0.200 |
Why?
|
| Thymus Neoplasms | 1 | 2006 | 400 | 0.200 |
Why?
|
| Mice, Inbred C57BL | 9 | 2019 | 6942 | 0.200 |
Why?
|
| Osmoregulation | 1 | 2020 | 2 | 0.200 |
Why?
|
| Feces | 1 | 2004 | 770 | 0.190 |
Why?
|
| Infertility | 1 | 2022 | 123 | 0.180 |
Why?
|
| DNA Fingerprinting | 2 | 1998 | 167 | 0.180 |
Why?
|
| Sex Distribution | 1 | 2021 | 495 | 0.180 |
Why?
|
| Macaca mulatta | 2 | 2022 | 717 | 0.180 |
Why?
|
| Interviews as Topic | 1 | 2021 | 497 | 0.170 |
Why?
|
| Mice, Congenic | 1 | 2019 | 30 | 0.170 |
Why?
|
| Genes, Modifier | 1 | 2019 | 11 | 0.170 |
Why?
|
| Tetradecanoylphorbol Acetate | 4 | 2011 | 226 | 0.170 |
Why?
|
| Mice, Inbred DBA | 3 | 2013 | 110 | 0.170 |
Why?
|
| Perception | 1 | 2021 | 350 | 0.170 |
Why?
|
| Qualitative Research | 1 | 2021 | 556 | 0.170 |
Why?
|
| Mice, 129 Strain | 1 | 2019 | 170 | 0.170 |
Why?
|
| Flagella | 1 | 2018 | 39 | 0.170 |
Why?
|
| Carcinogenesis | 3 | 2024 | 1026 | 0.160 |
Why?
|
| Papilloma | 2 | 2011 | 74 | 0.160 |
Why?
|
| Primate Diseases | 1 | 2018 | 20 | 0.160 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2017 | 986 | 0.160 |
Why?
|
| Lipoylation | 1 | 2017 | 8 | 0.160 |
Why?
|
| Lysosomes | 1 | 2020 | 347 | 0.160 |
Why?
|
| Adenoma | 1 | 2003 | 716 | 0.150 |
Why?
|
| Dynamins | 1 | 2017 | 74 | 0.150 |
Why?
|
| Disabled Persons | 2 | 2016 | 121 | 0.150 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2019 | 528 | 0.150 |
Why?
|
| Chemokine CXCL13 | 1 | 2017 | 21 | 0.150 |
Why?
|
| Receptors, CXCR5 | 1 | 2017 | 27 | 0.150 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2020 | 1331 | 0.150 |
Why?
|
| Work | 1 | 2017 | 24 | 0.150 |
Why?
|
| Stress, Physiological | 1 | 2020 | 492 | 0.150 |
Why?
|
| Quantitative Trait Loci | 1 | 2019 | 374 | 0.150 |
Why?
|
| Anion Transport Proteins | 1 | 2017 | 34 | 0.150 |
Why?
|
| Radiation Injuries, Experimental | 1 | 2017 | 82 | 0.150 |
Why?
|
| Motor Skills | 1 | 2017 | 107 | 0.150 |
Why?
|
| Socioeconomic Factors | 1 | 2021 | 1225 | 0.150 |
Why?
|
| Agammaglobulinemia | 1 | 2017 | 46 | 0.150 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2001 | 442 | 0.140 |
Why?
|
| Embryonic Stem Cells | 1 | 2019 | 301 | 0.140 |
Why?
|
| Gait | 1 | 2017 | 165 | 0.140 |
Why?
|
| Employment | 1 | 2017 | 129 | 0.140 |
Why?
|
| Neck Pain | 1 | 2016 | 39 | 0.140 |
Why?
|
| Shoulder Pain | 1 | 2016 | 31 | 0.140 |
Why?
|
| Genetic Heterogeneity | 1 | 1998 | 318 | 0.140 |
Why?
|
| Cyclooxygenase 2 | 1 | 2018 | 483 | 0.140 |
Why?
|
| Female | 27 | 2024 | 141928 | 0.130 |
Why?
|
| Promoter Regions, Genetic | 4 | 2012 | 3101 | 0.130 |
Why?
|
| Species Specificity | 3 | 2013 | 777 | 0.130 |
Why?
|
| Cross-Sectional Studies | 4 | 2021 | 4314 | 0.130 |
Why?
|
| Sequence Analysis, RNA | 1 | 2019 | 651 | 0.130 |
Why?
|
| Infertility, Male | 1 | 2018 | 297 | 0.130 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 3 | 2006 | 108 | 0.130 |
Why?
|
| Sick Leave | 1 | 2014 | 6 | 0.130 |
Why?
|
| Quality Control | 3 | 2004 | 457 | 0.130 |
Why?
|
| Colonic Neoplasms | 2 | 2022 | 1390 | 0.120 |
Why?
|
| Thymus Gland | 3 | 2017 | 294 | 0.120 |
Why?
|
| Cell Transformation, Neoplastic | 5 | 2024 | 2359 | 0.120 |
Why?
|
| Chromosome Mapping | 2 | 1999 | 1471 | 0.120 |
Why?
|
| Mice, Inbred C3H | 3 | 2013 | 385 | 0.120 |
Why?
|
| Male | 22 | 2021 | 123000 | 0.120 |
Why?
|
| Genotype | 4 | 2011 | 4109 | 0.120 |
Why?
|
| Polymorphism, Single Nucleotide | 4 | 2019 | 4549 | 0.120 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2020 | 1048 | 0.120 |
Why?
|
| Protein Kinase C-delta | 2 | 2011 | 42 | 0.110 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2015 | 5539 | 0.110 |
Why?
|
| Leukemia | 1 | 2022 | 1635 | 0.110 |
Why?
|
| Mice, Inbred AKR | 2 | 2006 | 51 | 0.110 |
Why?
|
| Protein Kinase C-alpha | 2 | 2011 | 66 | 0.110 |
Why?
|
| Cell Line, Tumor | 8 | 2020 | 14551 | 0.110 |
Why?
|
| Keratin-5 | 2 | 2012 | 57 | 0.110 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2019 | 1265 | 0.110 |
Why?
|
| Apoptosis | 6 | 2017 | 7591 | 0.110 |
Why?
|
| Computational Biology | 1 | 2019 | 1271 | 0.110 |
Why?
|
| Genetic Variation | 1 | 2000 | 2086 | 0.100 |
Why?
|
| Transcription Factor RelA | 1 | 2012 | 184 | 0.100 |
Why?
|
| Gene Expression Regulation | 3 | 2019 | 4053 | 0.100 |
Why?
|
| Energy Metabolism | 1 | 2017 | 992 | 0.100 |
Why?
|
| Genetic Markers | 3 | 2001 | 974 | 0.100 |
Why?
|
| Oncogenes | 1 | 1995 | 673 | 0.100 |
Why?
|
| Oxidoreductases | 1 | 2012 | 171 | 0.100 |
Why?
|
| Androgen-Binding Protein | 1 | 2011 | 39 | 0.100 |
Why?
|
| B-Lymphocytes | 1 | 2017 | 1294 | 0.100 |
Why?
|
| Ribosomal Protein S6 Kinases | 1 | 2011 | 116 | 0.100 |
Why?
|
| Health Personnel | 2 | 2006 | 625 | 0.100 |
Why?
|
| Administration, Topical | 1 | 2011 | 257 | 0.100 |
Why?
|
| Citrullinemia | 1 | 2010 | 19 | 0.100 |
Why?
|
| Integrases | 1 | 2012 | 262 | 0.090 |
Why?
|
| Neurocalcin | 1 | 2010 | 1 | 0.090 |
Why?
|
| Hyperplasia | 2 | 2009 | 557 | 0.090 |
Why?
|
| Genetic Engineering | 1 | 2012 | 288 | 0.090 |
Why?
|
| Argininosuccinate Synthase | 1 | 2010 | 54 | 0.090 |
Why?
|
| Prostate | 2 | 2018 | 1088 | 0.090 |
Why?
|
| Anxiety | 1 | 2017 | 1179 | 0.090 |
Why?
|
| Tumor Suppressor Proteins | 3 | 2010 | 1823 | 0.090 |
Why?
|
| Hyperammonemia | 1 | 2010 | 68 | 0.090 |
Why?
|
| Carcinogens | 3 | 2007 | 384 | 0.090 |
Why?
|
| Anions | 2 | 2020 | 39 | 0.090 |
Why?
|
| Carcinoma, Squamous Cell | 5 | 2010 | 5437 | 0.090 |
Why?
|
| Stress, Psychological | 1 | 2017 | 1000 | 0.090 |
Why?
|
| Prostatic Hyperplasia | 1 | 2011 | 210 | 0.090 |
Why?
|
| Ultraviolet Rays | 1 | 2012 | 575 | 0.090 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2013 | 488 | 0.090 |
Why?
|
| Glioblastoma | 1 | 2020 | 1797 | 0.090 |
Why?
|
| Photobiology | 1 | 2008 | 2 | 0.090 |
Why?
|
| Cell Proliferation | 6 | 2017 | 7226 | 0.080 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2017 | 3552 | 0.080 |
Why?
|
| Medroxyprogesterone Acetate | 2 | 2007 | 55 | 0.080 |
Why?
|
| Lung Neoplasms | 2 | 2020 | 11538 | 0.080 |
Why?
|
| NF-kappa B | 4 | 2018 | 1549 | 0.080 |
Why?
|
| Transcription Factors | 2 | 2021 | 5270 | 0.080 |
Why?
|
| Histocompatibility | 1 | 2008 | 168 | 0.080 |
Why?
|
| Mammary Glands, Animal | 1 | 2012 | 533 | 0.080 |
Why?
|
| Young Adult | 4 | 2021 | 21445 | 0.080 |
Why?
|
| Humans | 26 | 2024 | 261506 | 0.080 |
Why?
|
| Cell Differentiation | 3 | 2017 | 4078 | 0.080 |
Why?
|
| Asthma | 2 | 2006 | 871 | 0.080 |
Why?
|
| Phenotype | 5 | 2017 | 6295 | 0.080 |
Why?
|
| Microsatellite Instability | 2 | 2022 | 400 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2011 | 2054 | 0.080 |
Why?
|
| Ion Transport | 2 | 2018 | 79 | 0.080 |
Why?
|
| Proprotein Convertases | 1 | 2007 | 25 | 0.080 |
Why?
|
| Codon, Nonsense | 2 | 2021 | 164 | 0.080 |
Why?
|
| Gene Deletion | 1 | 2012 | 1442 | 0.070 |
Why?
|
| Cyclin D1 | 1 | 2009 | 576 | 0.070 |
Why?
|
| Signal Transduction | 7 | 2018 | 11965 | 0.070 |
Why?
|
| Methylnitrosourea | 1 | 2006 | 46 | 0.070 |
Why?
|
| Surveys and Questionnaires | 4 | 2017 | 5687 | 0.070 |
Why?
|
| Colorectal Neoplasms | 1 | 2022 | 3578 | 0.070 |
Why?
|
| Epidermis | 2 | 2008 | 188 | 0.070 |
Why?
|
| Hair Color | 2 | 1998 | 20 | 0.070 |
Why?
|
| Flow Cytometry | 2 | 2006 | 3033 | 0.070 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2011 | 1033 | 0.070 |
Why?
|
| Gastrointestinal Tract | 1 | 2008 | 324 | 0.070 |
Why?
|
| DNA-Binding Proteins | 1 | 2019 | 4821 | 0.070 |
Why?
|
| Cell Survival | 3 | 2020 | 3045 | 0.070 |
Why?
|
| Arachidonate Lipoxygenases | 1 | 2005 | 3 | 0.070 |
Why?
|
| Chromosome Banding | 1 | 2005 | 256 | 0.070 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2020 | 8873 | 0.070 |
Why?
|
| Tryptophan | 1 | 2005 | 127 | 0.070 |
Why?
|
| Genes, Tumor Suppressor | 2 | 2010 | 1064 | 0.070 |
Why?
|
| Lactobacillus plantarum | 1 | 2004 | 5 | 0.060 |
Why?
|
| Mutation, Missense | 1 | 2010 | 1152 | 0.060 |
Why?
|
| Cyclins | 1 | 2006 | 456 | 0.060 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2007 | 221 | 0.060 |
Why?
|
| Protein Kinases | 1 | 2009 | 874 | 0.060 |
Why?
|
| Phosphorylation | 2 | 2011 | 4804 | 0.060 |
Why?
|
| Skin Transplantation | 2 | 1998 | 173 | 0.060 |
Why?
|
| False Negative Reactions | 1 | 2004 | 275 | 0.060 |
Why?
|
| Neoplasms, Experimental | 2 | 2020 | 750 | 0.060 |
Why?
|
| Staurosporine | 1 | 2004 | 143 | 0.060 |
Why?
|
| STAT3 Transcription Factor | 1 | 2011 | 1121 | 0.060 |
Why?
|
| Brain | 1 | 2017 | 4113 | 0.060 |
Why?
|
| T-Lymphocytes | 1 | 2017 | 3869 | 0.060 |
Why?
|
| Protein Kinase C | 1 | 2005 | 396 | 0.060 |
Why?
|
| Mammary Tumor Virus, Mouse | 1 | 2024 | 122 | 0.060 |
Why?
|
| Cyclosporins | 1 | 2003 | 112 | 0.060 |
Why?
|
| Genes, MDR | 1 | 2003 | 38 | 0.060 |
Why?
|
| International Cooperation | 2 | 2016 | 323 | 0.060 |
Why?
|
| Wound Healing | 1 | 2008 | 815 | 0.060 |
Why?
|
| Adult | 6 | 2021 | 77950 | 0.060 |
Why?
|
| Brain Neoplasms | 1 | 2020 | 4849 | 0.060 |
Why?
|
| Leukemia, T-Cell | 1 | 2003 | 87 | 0.060 |
Why?
|
| Adolescent | 2 | 2021 | 31252 | 0.060 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2020 | 5319 | 0.060 |
Why?
|
| Lithiasis | 1 | 2002 | 7 | 0.050 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2024 | 216 | 0.050 |
Why?
|
| Drug Resistance, Multiple | 1 | 2003 | 204 | 0.050 |
Why?
|
| Cyclosporine | 1 | 2003 | 278 | 0.050 |
Why?
|
| Estrogen Receptor alpha | 1 | 2007 | 701 | 0.050 |
Why?
|
| Progestins | 1 | 2002 | 87 | 0.050 |
Why?
|
| Sequence Deletion | 2 | 2017 | 875 | 0.050 |
Why?
|
| Prevalence | 3 | 2017 | 3260 | 0.050 |
Why?
|
| Genes, Homeobox | 1 | 2021 | 147 | 0.050 |
Why?
|
| Receptors, Progesterone | 1 | 2007 | 1392 | 0.050 |
Why?
|
| Research Design | 1 | 2008 | 1544 | 0.050 |
Why?
|
| Pulmonary Alveoli | 1 | 2002 | 208 | 0.050 |
Why?
|
| Morphogenesis | 1 | 2002 | 337 | 0.050 |
Why?
|
| Middle Aged | 5 | 2021 | 86204 | 0.050 |
Why?
|
| Benzo(a)pyrene | 1 | 2020 | 35 | 0.050 |
Why?
|
| Vacuoles | 1 | 2020 | 51 | 0.050 |
Why?
|
| Rats, Wistar | 1 | 2022 | 562 | 0.050 |
Why?
|
| Isoenzymes | 2 | 2005 | 614 | 0.050 |
Why?
|
| Skin | 3 | 2017 | 1259 | 0.050 |
Why?
|
| COS Cells | 1 | 2020 | 377 | 0.050 |
Why?
|
| Mammals | 1 | 2022 | 361 | 0.050 |
Why?
|
| Exocytosis | 1 | 2020 | 111 | 0.050 |
Why?
|
| DNA Mismatch Repair | 1 | 2022 | 268 | 0.050 |
Why?
|
| Macrophage Activation | 1 | 2020 | 148 | 0.050 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2005 | 2232 | 0.040 |
Why?
|
| Gene Knockout Techniques | 1 | 2020 | 276 | 0.040 |
Why?
|
| Epitopes | 1 | 2022 | 685 | 0.040 |
Why?
|
| Disease Outbreaks | 1 | 2022 | 415 | 0.040 |
Why?
|
| RNA, Viral | 1 | 2022 | 671 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2012 | 6009 | 0.040 |
Why?
|
| Dermatitis | 1 | 1999 | 60 | 0.040 |
Why?
|
| CD4 Antigens | 1 | 1999 | 170 | 0.040 |
Why?
|
| Biological Transport, Active | 1 | 2018 | 131 | 0.040 |
Why?
|
| Protein Binding | 2 | 2017 | 3438 | 0.040 |
Why?
|
| Electrophoresis, Cellulose Acetate | 1 | 1998 | 2 | 0.040 |
Why?
|
| Transcriptome | 2 | 2020 | 1859 | 0.040 |
Why?
|
| H-2 Antigens | 1 | 1998 | 42 | 0.040 |
Why?
|
| Aerobiosis | 1 | 2017 | 30 | 0.040 |
Why?
|
| Estrogens | 1 | 2002 | 751 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2004 | 2488 | 0.040 |
Why?
|
| Crosses, Genetic | 2 | 2000 | 241 | 0.040 |
Why?
|
| Healthy Volunteers | 1 | 2018 | 187 | 0.040 |
Why?
|
| Sperm Motility | 1 | 2018 | 106 | 0.040 |
Why?
|
| Blotting, Western | 3 | 2010 | 3536 | 0.040 |
Why?
|
| Behavior, Animal | 2 | 2017 | 709 | 0.040 |
Why?
|
| Locomotion | 1 | 2017 | 84 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2022 | 2063 | 0.040 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1998 | 568 | 0.040 |
Why?
|
| China | 1 | 2018 | 606 | 0.040 |
Why?
|
| Adenocarcinoma | 3 | 2018 | 7789 | 0.040 |
Why?
|
| Cell Size | 1 | 2017 | 136 | 0.040 |
Why?
|
| Risk Factors | 4 | 2017 | 17523 | 0.040 |
Why?
|
| Workplace | 1 | 2017 | 76 | 0.040 |
Why?
|
| Lung Diseases | 1 | 2002 | 717 | 0.040 |
Why?
|
| Cell Movement | 2 | 2017 | 2466 | 0.040 |
Why?
|
| Epidemiologic Studies | 1 | 2016 | 60 | 0.030 |
Why?
|
| Income | 1 | 2017 | 222 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2020 | 1489 | 0.030 |
Why?
|
| Spermatozoa | 1 | 2018 | 315 | 0.030 |
Why?
|
| Homeodomain Proteins | 1 | 2021 | 1143 | 0.030 |
Why?
|
| Immunity, Innate | 1 | 2020 | 677 | 0.030 |
Why?
|
| Workload | 1 | 2017 | 198 | 0.030 |
Why?
|
| Codon, Terminator | 1 | 2015 | 42 | 0.030 |
Why?
|
| Bromodeoxyuridine | 1 | 2015 | 139 | 0.030 |
Why?
|
| Aged | 1 | 2021 | 70117 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 2017 | 644 | 0.030 |
Why?
|
| Homeostasis | 1 | 2020 | 950 | 0.030 |
Why?
|
| Leukocyte Elastase | 1 | 2015 | 70 | 0.030 |
Why?
|
| Neutrophil Infiltration | 1 | 2015 | 109 | 0.030 |
Why?
|
| NIH 3T3 Cells | 1 | 2015 | 260 | 0.030 |
Why?
|
| Age Factors | 2 | 2016 | 5377 | 0.030 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2017 | 316 | 0.030 |
Why?
|
| Spleen | 1 | 2017 | 676 | 0.030 |
Why?
|
| Mice, Obese | 1 | 1995 | 104 | 0.030 |
Why?
|
| Immunohistochemistry | 2 | 2004 | 7548 | 0.030 |
Why?
|
| Developing Countries | 1 | 2017 | 315 | 0.030 |
Why?
|
| Base Sequence | 2 | 2013 | 4917 | 0.030 |
Why?
|
| Glycolysis | 1 | 2017 | 519 | 0.030 |
Why?
|
| Sweden | 1 | 2014 | 70 | 0.030 |
Why?
|
| Netherlands | 1 | 2014 | 83 | 0.030 |
Why?
|
| Age Distribution | 1 | 2016 | 698 | 0.030 |
Why?
|
| Spain | 1 | 2014 | 113 | 0.030 |
Why?
|
| National Health Programs | 1 | 2014 | 42 | 0.030 |
Why?
|
| Disease Progression | 4 | 2009 | 6682 | 0.030 |
Why?
|
| Testis | 1 | 2018 | 717 | 0.030 |
Why?
|
| Laminin | 1 | 1994 | 194 | 0.030 |
Why?
|
| Receptor, ErbB-2 | 1 | 2024 | 2518 | 0.030 |
Why?
|
| Metabolomics | 1 | 2017 | 478 | 0.030 |
Why?
|
| Inbreeding | 1 | 1993 | 11 | 0.030 |
Why?
|
| Immunologic Techniques | 1 | 1993 | 43 | 0.030 |
Why?
|
| Antibodies | 1 | 2017 | 838 | 0.030 |
Why?
|
| Proteoglycans | 1 | 1994 | 259 | 0.030 |
Why?
|
| Isoantigens | 1 | 1993 | 62 | 0.030 |
Why?
|
| Cell Cycle Proteins | 1 | 2002 | 2045 | 0.030 |
Why?
|
| Animal Husbandry | 1 | 1993 | 42 | 0.030 |
Why?
|
| Luciferases, Renilla | 1 | 2012 | 9 | 0.030 |
Why?
|
| Genome | 1 | 1997 | 672 | 0.030 |
Why?
|
| Type C Phospholipases | 1 | 2012 | 53 | 0.030 |
Why?
|
| Matrix Metalloproteinase 9 | 2 | 2010 | 360 | 0.030 |
Why?
|
| Exons | 2 | 2009 | 1328 | 0.030 |
Why?
|
| NF-KappaB Inhibitor alpha | 1 | 2012 | 136 | 0.030 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2020 | 1586 | 0.030 |
Why?
|
| DNA | 1 | 2001 | 2693 | 0.030 |
Why?
|
| Intestines | 1 | 2017 | 686 | 0.030 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2012 | 77 | 0.030 |
Why?
|
| Time Factors | 3 | 2014 | 12926 | 0.030 |
Why?
|
| Mental Health | 1 | 2016 | 415 | 0.030 |
Why?
|
| WW Domain-Containing Oxidoreductase | 1 | 2012 | 50 | 0.030 |
Why?
|
| Genome, Human | 1 | 2001 | 1869 | 0.030 |
Why?
|
| Positron Emission Tomography Computed Tomography | 1 | 2018 | 833 | 0.030 |
Why?
|
| I-kappa B Proteins | 1 | 2012 | 170 | 0.030 |
Why?
|
| DNA Methylation | 1 | 2022 | 2669 | 0.030 |
Why?
|
| Lymphocyte Activation | 1 | 2017 | 1688 | 0.030 |
Why?
|
| Incidence | 2 | 2014 | 5673 | 0.030 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2012 | 323 | 0.030 |
Why?
|
| Genomics | 1 | 2022 | 2738 | 0.020 |
Why?
|
| Collagen | 1 | 1994 | 752 | 0.020 |
Why?
|
| Sodium Benzoate | 1 | 2010 | 7 | 0.020 |
Why?
|
| Mice, Inbred NOD | 1 | 2013 | 905 | 0.020 |
Why?
|
| Phylogeny | 1 | 2013 | 826 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2020 | 6207 | 0.020 |
Why?
|
| Mitochondria | 1 | 2017 | 1282 | 0.020 |
Why?
|
| Epithelial Cells | 2 | 2008 | 1818 | 0.020 |
Why?
|
| Mice, Nude | 2 | 1995 | 4307 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2009 | 1678 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2012 | 798 | 0.020 |
Why?
|
| Research | 1 | 1993 | 415 | 0.020 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2010 | 66 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2020 | 2864 | 0.020 |
Why?
|
| Bone Marrow | 1 | 2017 | 2358 | 0.020 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2003 | 5178 | 0.020 |
Why?
|
| Head and Neck Neoplasms | 1 | 2004 | 3976 | 0.020 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 2008 | 110 | 0.020 |
Why?
|
| Growth Disorders | 1 | 2010 | 218 | 0.020 |
Why?
|
| Tongue | 1 | 2008 | 77 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2018 | 6100 | 0.020 |
Why?
|
| Models, Biological | 1 | 2017 | 3254 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2017 | 5637 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2010 | 1165 | 0.020 |
Why?
|
| Simian virus 40 | 1 | 2008 | 137 | 0.020 |
Why?
|
| Introns | 1 | 2009 | 432 | 0.020 |
Why?
|
| Sex Factors | 1 | 2013 | 2139 | 0.020 |
Why?
|
| Disease Susceptibility | 1 | 2010 | 538 | 0.020 |
Why?
|
| Neovascularization, Pathologic | 1 | 1994 | 1547 | 0.020 |
Why?
|
| Arginine | 1 | 2010 | 500 | 0.020 |
Why?
|
| Radioimmunoassay | 1 | 2007 | 191 | 0.020 |
Why?
|
| Syndrome | 1 | 2010 | 1351 | 0.020 |
Why?
|
| RNA, Messenger | 2 | 2009 | 6150 | 0.020 |
Why?
|
| Cyclin D3 | 1 | 2006 | 23 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2012 | 1538 | 0.020 |
Why?
|
| Cyclin D2 | 1 | 2006 | 40 | 0.020 |
Why?
|
| DNA Primers | 1 | 2009 | 1399 | 0.020 |
Why?
|
| Neoplasm Transplantation | 2 | 2004 | 1519 | 0.020 |
Why?
|
| Biomarkers | 1 | 2018 | 5047 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2017 | 5112 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2009 | 1062 | 0.020 |
Why?
|
| Cerebellum | 1 | 2010 | 449 | 0.020 |
Why?
|
| Nitric Oxide | 1 | 2010 | 644 | 0.020 |
Why?
|
| Hazardous Substances | 1 | 2006 | 27 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2013 | 6089 | 0.020 |
Why?
|
| Hormones | 1 | 2007 | 266 | 0.020 |
Why?
|
| Developmental Disabilities | 1 | 2010 | 674 | 0.020 |
Why?
|
| Caspase 8 | 1 | 2005 | 145 | 0.020 |
Why?
|
| Linoleic Acids, Conjugated | 1 | 2005 | 3 | 0.020 |
Why?
|
| Hydroxyeicosatetraenoic Acids | 1 | 2005 | 35 | 0.020 |
Why?
|
| Health Surveys | 1 | 2006 | 402 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2006 | 591 | 0.020 |
Why?
|
| Sirolimus | 1 | 2009 | 814 | 0.020 |
Why?
|
| Progesterone | 1 | 2007 | 513 | 0.020 |
Why?
|
| Mouth Mucosa | 1 | 2004 | 216 | 0.010 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 1 | 2003 | 176 | 0.010 |
Why?
|
| Estradiol | 1 | 2007 | 748 | 0.010 |
Why?
|
| bcl-X Protein | 1 | 2003 | 196 | 0.010 |
Why?
|
| Transgenes | 1 | 2005 | 557 | 0.010 |
Why?
|
| Genes, bcl-2 | 1 | 2003 | 166 | 0.010 |
Why?
|
| Androgens | 1 | 2005 | 511 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 3639 | 0.010 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2003 | 367 | 0.010 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2002 | 93 | 0.010 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2009 | 1546 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 2002 | 185 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 2 | 2003 | 5395 | 0.010 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2003 | 299 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2005 | 1113 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2002 | 287 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2016 | 14889 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2004 | 1764 | 0.010 |
Why?
|
| Chimera | 1 | 2000 | 145 | 0.010 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2003 | 560 | 0.010 |
Why?
|
| Mitosis | 1 | 2002 | 615 | 0.010 |
Why?
|
| Vincristine | 1 | 2003 | 1511 | 0.010 |
Why?
|
| Genes, Recessive | 1 | 1999 | 200 | 0.010 |
Why?
|
| Genetic Linkage | 1 | 1999 | 512 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2006 | 4971 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2003 | 2084 | 0.010 |
Why?
|
| Cell Line | 1 | 2005 | 5114 | 0.010 |
Why?
|
| Haplotypes | 1 | 1999 | 856 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2003 | 1493 | 0.010 |
Why?
|
| Gene Expression | 1 | 2005 | 3570 | 0.010 |
Why?
|
| Doxorubicin | 1 | 2003 | 3005 | 0.010 |
Why?
|
| T-Lymphocyte Subsets | 1 | 1999 | 582 | 0.010 |
Why?
|
| Stimulation, Chemical | 1 | 1994 | 97 | 0.010 |
Why?
|
| Collagenases | 1 | 1994 | 74 | 0.010 |
Why?
|
| Chemotaxis | 1 | 1994 | 138 | 0.010 |
Why?
|
| Carcinoma | 1 | 2005 | 2578 | 0.010 |
Why?
|
| Drug Combinations | 1 | 1994 | 621 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 2003 | 3230 | 0.010 |
Why?
|
| Antineoplastic Agents | 2 | 2004 | 14289 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2013 | 37905 | 0.010 |
Why?
|
| Cell Division | 1 | 1994 | 2489 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 1994 | 891 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2004 | 4757 | 0.010 |
Why?
|
| Neoplasms | 1 | 1994 | 15193 | 0.000 |
Why?
|
| Breast Neoplasms | 1 | 1994 | 15694 | 0.000 |
Why?
|